November 16, 2016 — Dilon Diagnostics and GE Healthcare announced the signing of an agreement for Dilon to be the exclusive distributor of GE's Discovery NM750b molecular breast imaging system in North America. Last year, GE Healthcare and Dilon Diagnostics signed a global distribution agreement in select world markets.
The Discovery NM750b offers clinicians a tool for imaging of a broad range of patients, including those with dense breasts who may be at higher risk for breast cancer. The power of functional imaging to see early changes is a key factor in early detection in breast cancer.
For more information: www.gehealthcare.com, www.dilon.com
September 04, 2026 
